Menlo Park, Calif.-based Asterias Biotherapeutics announced the sixth and final patient who was administered AST-OPC1 after complete paralysis has exhibited positive signs following the six month study.
Spinal Tech
Fibrosis, the creation of dense scar tissue, often occurs around implanted medical devices, which inhibits the devices from performing their intended duties.
Richard H. Bundschu, MD, of Bradenton, Fla.-based Coastal Orthopedics Sports Medicine & Pain Management, is a principal investigator for a spinal cord stimulator study.
Hartford (Conn.) HealthCare is the first healthcare system in Connecticut to utilize Caesarea, Israel-based Mazor Robotics' Mazor X for spine surgeries.
The global robotics market will likely reach $13 billion by 2023, based on a Research Nester report, according to I-Connect007.
Advertisement
Houston-based Spine Injury Solutions, also known as SPIN, opened a Lubbock, Texas location as part of its affiliate expansion program.
Cambridge, Mass.-based InVivo Therapeutics announced the newest patient enrollee into its Inspire Study at Camden, N.J.-based Cooper Neurological Institute.
Johnson & Johnson CEO Alex Gorsky spoke to CNBC about the U.S. healthcare system from the China Development Forum in Beijing.
Caesarea, Israel-based Mazor Robotics has teamed up with Dublin, Ireland-based Medtronic to co-market and promote the Mazor X, according to Yahoo! Finance.
The global hip replacement implant market is anticipated to reach $9.1 billion by 2024, based on a Transparency Market Research analysis, according to medGadget.